Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director comp.
Appointed director
CC transcript
Asset disposition
Quarterly results
Appointed CFO
ImmunoGen, Inc. (IMGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/31/2023 8-K Quarterly results
06/16/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "Amended and Restated By-Laws, marked for amendments"
05/05/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Underwriting Agreement",
"Letter re: Registration Statement on Form S-3",
"PART II INFORMATION NOT REQUIRED IN PROSPECTUS Item 14. Other Expenses of Issuance and Distribution."
05/03/2023 8-K Quarterly results
05/02/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "Articles of Amendment",
"Exchange Agreement, by and among ImmunoGen, Inc. and RA Capital Healthcare Fund, L.P"
04/28/2023 8-K Quarterly results
04/06/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "ImmunoGen Announces Non-Dilutive Term Loan Financing for Up to"
03/01/2023 8-K Quarterly results
03/01/2023 8-K Quarterly results
01/09/2023 8-K Investor presentation
Docs: "Corporate Presentation for 41st Annual JP Morgan Healthcare Conference"
01/04/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "ImmunoGen Appoints Michael Vasconcelles, MD,"
12/28/2022 8-K Quarterly results
11/14/2022 8-K Quarterly results
11/04/2022 8-K Quarterly results
11/01/2022 8-K Quarterly results
08/31/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "MEDIA CONTACTS"
07/29/2022 8-K Quarterly results
06/17/2022 8-K Quarterly results
05/23/2022 8-K Quarterly results
05/06/2022 8-K Quarterly results
02/25/2022 8-K Quarterly results
02/16/2022 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
01/10/2022 8-K Investor presentation
Docs: "Corporate Presentation for 40th Annual JP Morgan Healthcare Conference"
12/03/2021 8-K Quarterly results
11/30/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "ImmunoGen Announces Positive Top-Line Results from Pivotal SORAYA Trial of Mirvetuximab Soravtansine in Ovarian Cancer"
11/17/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/29/2021 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
09/23/2021 8-K Quarterly results
08/12/2021 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "SCHEDULE 1",
"Letter re: Registration Statement on Form S-3",
"BACKGROUND"
07/30/2021 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
06/17/2021 8-K Quarterly results
05/10/2021 8-K Quarterly results
02/12/2021 8-K Quarterly results
01/11/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy